Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
Go back to Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand| (NASDAQ: EOLS) | Delayed: 8.98 +0.01 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.97 | 52 Week High | $ | |||
| Open | $8.86 | 52 Week Low | $ | |||
| Day High | $9.08 | P/E | N/A | |||
| Day Low | $8.86 | EPS | $ | |||
| Volume | 373,455 | |||||

